Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China

/PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application...

Related Keywords

China ,Taiwan ,United States ,Shanghai ,Hong Kong ,Macau ,Chinese ,Mark Lotter ,Haijin Meng ,David Zaccardelli ,Vicky Lin ,Verona Pharma ,Asia Pacific ,Markg Lotter ,National Health Interview ,Nuance Pharma ,Global Initiative ,China The Pulmonary Health ,Drug Administration For Ensifentrine ,Nuance Pharma The Company ,Drug Evaluation ,Investigational New Drug ,New Drug Application ,Drug Administration ,Ensifentrine Chinese ,Greater China ,Chief Executive Officer ,Dual Wheel ,Investor Relations ,Opin Investig ,Health Interview Survey ,Mortal Wkly ,China Pulmonary Health ,Nuance Pharma Limited ,